arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Sanara MedTech Inc.

SMTI

$34.09 ▲ +0.03 (+0.09%) at close

15 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Sanara MedTech Inc. faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $294.0M

Dividend Yield —

Revenue Growth 19.0% ↘

Op. Margin 7.1% ↗

ROIC 11.1% ↗

FCF / Share $0.25 ↗

Trailing P/E —

Price / Book 51.4x

FCF Yield 0.7%

Debt / Equity 7.74

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$103.12M

↑ +19.0% —

Net Income Profit after all expenses

$-37.56M

↓ -288.7% —

Operating Margin Operating profit as % of sales

7.1%

↑ +387.7% 49th

FCF / Share Free cash flow per share

$0.25

↑ +1025.9% —

Long-Term Debt Long-term obligations

$45.97M

↑ +49.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	19.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+137%)	33.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+317%)	41.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+422%)	89.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1023%)	105.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1215%)	101.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1170%)	-7.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-193%)	14.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+81%)	63.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+692%)	28.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+251%)	52.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+556%)	47.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+489%)	-46.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-686%)	—	—
EPS Growth YoY (%)	-282.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-119.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	48.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	7.4% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	18.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-288.7% Weak ↓ Weak Declining Year-over-year change in net income	-124.6% Weak ↓ Weak Declining Year-over-year change in net income	45.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.2% Weak ↑ Weak Improving Year-over-year change in net income	-181.5% Weak Weak Year-over-year change in net income	-368.6% Weak Weak Year-over-year change in net income	N/M	N/M	69.0% Excellent ↑ Excellent Improving Year-over-year change in net income	41.2% Excellent ↑ Excellent Improving Year-over-year change in net income	45.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-124.8% Weak Weak Year-over-year change in net income	85.5% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	93.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	41.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-6.2% Weak Weak Year-over-year change in free cash flow	38.4% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	N/M	N/M	41.2% Excellent Excellent Year-over-year change in free cash flow	19.1% Good Good Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	31.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	53.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	76.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	98.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	56.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	28.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	20.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	33.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	47.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	42.2% Excellent Excellent Compound annual revenue growth over 3 years	6.0% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	54.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	71.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	59.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	52.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	48.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	34.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	27.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	40.0% Excellent Excellent Compound annual revenue growth over 5 years	20.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	7.1% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-53%)	1.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-90%)	-6.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-143%)	-26.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-278%)	-30.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	-23.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-255%)	-8.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-157%)	1.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-87%)	-4.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-133%)	-28.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-291%)	—	—	—	—	—
Effective Tax Rate (%) (%)	—	-2.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	41.9% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-36.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-404%)	-11.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-193%)	-6.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-155%)	-17.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-244%)	-32.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-373%)	-23.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-299%)	-10.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-186%)	5.3% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-56%)	-7.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-163%)	-39.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-431%)	-86.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-821%)	-240.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2102%)	-157.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1410%)	—	—
FCF Margin (%) (%)	2.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.4% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-20.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-20.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	4.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-2.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.4% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-35.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-64.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-107.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-104.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-15.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.98x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	11.1% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	92.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	50.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	60.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	10.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	1.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-20.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	5.4% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-12.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-69.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	—	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-9.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-19.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	-25.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-42.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-384%)	-54.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-460%)	—	98.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+555%)	105.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+603%)	276.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1740%)	168.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1020%)	48.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+223%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Debt to Equity (x)	7.74x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1190%)	0.78x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+30%)	0.22x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	1.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-42.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10374.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.87x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.80x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$29.39M	$14.81M	$4.55M	$-8.96M	$-18.65M	$-6.61M	$-731.85K	$-463.19K	$-833.48K	$-182.34K	$-523.44K	$-44.55K	$-45.86K	$-3.61K	$-50.84K
Debt / EBITDA (x)	4.09x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.96x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.58x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$11.96	$10.22	$7.85	$5.80	$3.29	$5.52	$0.03	$0.06	$0.05	$0.03	$0.03	$0.02	—	—	—
Basic EPS, GAAP (USD)	$-4.36	$-1.14	$-0.52	$-1.00	$-1.08	$-1.32	$0.00	$0.00	$-0.01	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.25	$-0.03	$-0.42	$-0.72	$-0.68	$-1.10	$0.00	$-0.00	$0.00	$-0.01	$-0.02	$-0.02	—	—	—
Book Value per Share (USD)	$0.66	$4.50	$5.25	$5.04	$3.99	$1.85	$0.00	$0.00	$-0.00	$-0.01	$-0.01	$-0.03	$-0.06	$-0.07	—
Tangible Book Value per Share (USD)	$-1.82	$1.41	$-0.43	$0.81	$3.38	$1.44	$0.00	$-0.00	$-0.01	$-0.01	$-0.01	$-0.03	$-0.06	$-0.07	—
Basic Weighted Avg Shares (shares)	8.62M	8.48M	8.28M	7.91M	7.34M	2.13M	217.16M	111.38M	108.60M	106.70M	87.94M	77.71M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Working Capital (USD)	$14.92M	$18.02M	$5.24M	$7.81M	$18.59M	$6.22M	$574.48K	$-77.96K	$601.65K	$-300.42K	$-1.10M	$-2.79M	$-3.97M	$-5.29M	—
LT Debt (USD)	$45.97M	$30.69M	$9.69M	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$5.94M	$39.40M	$44.83M	$41.83M	$30.64M	$6.61M	$1.11M	$102.54K	$-423.07K	$-1.27M	$-825.40K	$-2.47M	$-3.81M	$-3.86M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$103.12M	$86.67M	$64.99M	$45.84M	$24.14M	$11.77M	$5.84M	$6.30M	$5.51M	$3.37M	$2.63M	$1.73M	$1.17M	$2.21M	—
Depreciation Expense (USD)	$3.95M	$4.92M	$456.14K	$407.77K	$220.57K	$119.95K	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-37.56M	$-9.66M	$-4.30M	$-7.94M	$-7.92M	$-2.81M	$-600.57K	$331.31K	$-415.75K	$-1.34M	$-2.28M	$-4.15M	$-1.85M	$-12.74M	—
Operating Cash Flow (USD)	$6.79M	$-23.78K	$-3.25M	$-5.55M	$-4.81M	$-2.17M	$277.14K	$-139.86K	$409.25K	$-1.20M	$-1.69M	$-1.82M	$-1.23M	$-343.60K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 58 quarters

Sanara MedTech Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SMTI with peers